div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV Brzo sc konver- tuje u metabolit hydrodolasetron koji se pokazao src=https:reader033fdocumentsnetreader033viewer20220502045f5757d806e75d07ef6ddce3html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV Brzo sc konver- tuje u metabolit hydrodolasetron koji se pokazao src=https:reader033fdocumentsnetreader033viewer20220502045f5757d806e75d07ef6ddce3html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV Brzo sc konver- tuje u metabolit hydrodolasetron koji se pokazao src=https:reader033fdocumentsnetreader033viewer20220502045f5757d806e75d07ef6ddce3html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV Brzo sc konver- tuje u metabolit hydrodolasetron koji se pokazao src=https:reader033fdocumentsnetreader033viewer20220502045f5757d806e75d07ef6ddce3html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: National Library of Serbia · Dolasetron - najnoviji 5-HT3 antagonista ispiti- van u tretmanu i prevenciji PONV Brzo sc konver- tuje u metabolit hydrodolasetron koji se pokazao...